Published October 21, 2022 | Version v1
Dataset Open

Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study

  • 1. Infectious Diseases Institute

Description

Background

The tuberculin skin test is commonly used to diagnose latent tuberculosis infection (LTBI) in resource-limited settings, but its specificity is limited by factors including cross-reactivity with BCG vaccine and environmental mycobacteria. Interferon-gamma release assays (IGRA) overcome this problem by detecting M. tuberculosis complex-specific responses, but studies to determine risk factors for IGRA-positivity in high TB burden settings are lacking.

Methods

We conducted a cross-sectional study to determine factors associated with a positive IGRA by employing the QuantiFERON-TB® Gold-plus (QFT Plus) assay in a cohort of asymptomatic adult TB contacts in Kampala, Uganda. Multivariate logistic regression analysis with forward stepwise logit function was employed to identify independent correlates of QFT Plus-positivity.

Results

Of the 202 participants enrolled, 129/202 (64%) were female, 173/202 (86%) had a BCG scar, and 67/202 (33%) were HIV-infected. Overall, 105/192 (54%, 95% CI 0.48–0.62) participants had a positive QFT Plus result. Increased risk of QFT-Plus positivity was independently associated with manual employment/unemployment vs. professional employment (adjusted odds ratio (aOR) 2.18, 95% CI 1.01–4.72), a family vs. non-family relation to the index patient (aOR 2.87, 95% CI 1.33–6.18), living in the same vs. a different house as the index (aOR 3.05, 95% CI 1.28–7.29), a higher body mass index (BMI) (aOR per additional kg/m2 1.09, 95% CI 1.00–1.18) and tobacco smoking vs. not (aOR 2.94, 95% CI 1.00–8.60). HIV infection was not associated with QFT-Plus positivity (aOR 0.91, 95% CI 0.42–1.96).

Conclusion

The prevalence of IGRA positivity in this study population was lower than previously estimated. Tobacco smoking and raised BMI are hitherto unappreciated determinants of LTBI risk in this setting.

Notes

Excel

Funding provided by: Wellcome Trust
Crossref Funder Registry ID: http://dx.doi.org/10.13039/100010269
Award Number: 107742/Z/15/Z

Files

Files (83.8 kB)

Name Size Download all
md5:469378e547bd4c6d32e3239e319cccc6
57.2 kB Download
md5:d19fcac5f78748c0d603a332f8caa481
26.6 kB Download